A detailed history of State Street Corp transactions in Evolus, Inc. stock. As of the latest transaction made, State Street Corp holds 1,277,841 shares of EOLS stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,277,841
Previous 1,339,077 4.57%
Holding current value
$13.9 Million
Previous $14.5 Million 42.49%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.66 - $17.48 $652,775 - $1.07 Million
-61,236 Reduced 4.57%
1,277,841 $20.7 Million
Q2 2024

Aug 14, 2024

BUY
$10.45 - $13.76 $3.2 Million - $4.22 Million
306,509 Added 29.68%
1,339,077 $14.5 Million
Q1 2024

May 15, 2024

BUY
$9.99 - $14.91 $61,878 - $92,352
6,194 Added 0.6%
1,032,568 $14.5 Million
Q4 2023

Feb 14, 2024

BUY
$7.6 - $10.53 $317,915 - $440,480
41,831 Added 4.25%
1,026,374 $10.8 Million
Q3 2023

Nov 14, 2023

BUY
$7.15 - $10.2 $1.28 Million - $1.83 Million
179,121 Added 22.24%
984,543 $9 Million
Q2 2023

Aug 14, 2023

BUY
$7.23 - $10.52 $398,062 - $579,199
55,057 Added 7.34%
805,422 $5.86 Million
Q1 2023

May 15, 2023

BUY
$7.81 - $11.05 $165,564 - $234,248
21,199 Added 2.91%
750,365 $6.35 Million
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.95 $1.23 Million - $1.69 Million
-188,487 Reduced 20.54%
729,166 $5.48 Million
Q3 2022

Nov 15, 2022

BUY
$7.76 - $13.72 $344,024 - $608,248
44,333 Added 5.08%
917,653 $7.39 Million
Q2 2022

Aug 15, 2022

BUY
$10.22 - $13.94 $1.83 Million - $2.5 Million
179,111 Added 25.8%
873,320 $10.1 Million
Q1 2022

May 16, 2022

BUY
$5.22 - $11.78 $123,051 - $277,689
23,573 Added 3.52%
694,209 $7.79 Million
Q4 2021

Feb 14, 2022

SELL
$5.37 - $8.38 $41,220 - $64,324
-7,676 Reduced 1.13%
670,636 $4.37 Million
Q3 2021

Nov 15, 2021

BUY
$7.36 - $13.67 $1.04 Million - $1.93 Million
141,072 Added 26.26%
678,312 $5.17 Million
Q2 2021

Aug 16, 2021

BUY
$8.42 - $13.96 $1.19 Million - $1.98 Million
141,825 Added 35.87%
537,240 $6.8 Million
Q1 2021

May 17, 2021

BUY
$3.2 - $16.51 $172,921 - $892,167
54,038 Added 15.83%
395,415 $5.14 Million
Q4 2020

Feb 16, 2021

SELL
$2.92 - $4.84 $21,605 - $35,811
-7,399 Reduced 2.12%
341,377 $1.15 Million
Q3 2020

Nov 10, 2020

BUY
$3.03 - $5.48 $11,850 - $21,432
3,911 Added 1.13%
348,776 $1.36 Million
Q2 2020

Aug 14, 2020

SELL
$3.53 - $6.17 $49,282 - $86,139
-13,961 Reduced 3.89%
344,865 $1.83 Million
Q1 2020

May 11, 2020

BUY
$3.53 - $12.21 $1.27 Million - $4.38 Million
358,826 New
358,826 $1.49 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $611M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.